- Home
- VOYA vs CNTA Comparison
VOYA vs CNTA Comparison
Compare VOYA & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VOYA | CNTA |
|---|---|---|
| Founded | 1975 | 2020 |
| Country | United States | United Kingdom |
| Employees | 11000 | N/A |
| Industry | Life Insurance | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.4B | 6.1B |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | VOYA | CNTA |
|---|---|---|
| Price | $80.08 | $39.58 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 9 |
| Target Price | ★ $84.90 | $43.17 |
| AVG Volume (30 Days) | 1.4M | ★ 2.1M |
| Earning Date | 05-05-2026 | 05-13-2026 |
| Dividend Yield | ★ 2.31% | N/A |
| EPS Growth | N/A | ★ 29.13 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $15,000,000.00 |
| Revenue This Year | $3.13 | N/A |
| Revenue Next Year | $3.93 | N/A |
| P/E Ratio | $12.00 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $64.50 | $10.95 |
| 52 Week High | $84.00 | $40.26 |
Technical Indicators
Market Signals| Indicator | VOYA | CNTA |
|---|---|---|
| Relative Strength Index (RSI) | 58.64 | 71.98 |
| Support Level | $73.34 | $39.36 |
| Resistance Level | $79.99 | $40.26 |
| Average True Range (ATR) | 2.86 | 0.15 |
| MACD | -0.25 | -0.41 |
| Stochastic Oscillator | 59.05 | 44.16 |
Price Performance
Historical ComparisonAbout VOYA Voya Financial Inc.
Voya Financial Inc is a financial services company, which, through its subsidiaries, provides various investment, insurance, and retirement solutions to individual and institutional clients in the United States. Its products and services include tax savings plans, individual retirement accounts, group life insurance plans, and employee benefits products, among others. The company tailors each of its products to the needs of its customer base. It operates its business through three principal lines: Retirement, Investment Management and Employee Benefits.The majority revenue is from Retirement segment.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage biotechnology company pioneering a new class of therapeutics in orexin-based neuroscience. The group is developing a franchise of small molecule orexin receptor 2 (OX2R) agonists designed to address neuroscience diseases underpinned by dysregulation of wakefulness, attention, cognition, mood, and other symptoms, each grounded in the shared biology of the orexin pathway. The company's programs and Pipeline are the Orexin Receptor 2 Agonist Program and LockBody Technology Platform.